ArticleInternational journal of molecular sciences2022

A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.

Rujia Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.